Skip directly to content

Supporting Australian scientists

In Australia, Monash University became the first academic institution outside the United States to join Pfizer’s network of research partners in the CTI network. In 2015 Pfizer also formed a partnership with the University of Queensland (UQ) to advance drug discovery in Australia. The agreement with UniQuest, UQ’s commercialisation arm, is focussed on vaccines, oncology, infectious diseases, peptides and advanced imaging, inflammation and immunology, and neuroscience and pain.

A third partnership was formed with the University of Melbourne in 2016, which has strong capabilities in the areas of neuroscience, infection, inflammation and immunity, and oncology.